[Vascular fragility of the endometrium under estrogen-progestin treatment. Treatment by disodium flavodate]

R Sarfati; J Brux; J De Brux

[Vascular fragility of the endometrium under estrogen-progestin treatment. Treatment by disodium flavodate]

R Sarfati, J Brux, J De Brux

Journal de gynecologie, obstetrique et biologie de la reproduction · 1976 · vol. 2(1) , pp. 87–94 · PMID:4807231 · W2423493639

Other OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View on OpenAlex View on PubMed

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-07 ⓘ

Disodium flavodate treatment was investigated for its effects on vascular fragility in the endometrium during estrogen-progestin therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Endometrium Estrogens Flavonoids Progestins Uterine Diseases Adult Endometrium Endometrium Estrogens Female Flavonoids Humans Progestins Uterine Diseases Uterine Diseases

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

The Clinical Relevance of Disturbances of Uterine Vascular Growth, Remodeling, and Repair 2001

Cited by (1)

The Clinical Relevance of Disturbances of Uterine Vascular Growth, Remodeling, and Repair 2001

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-10-08T21:57:27.106718+00:00

License: CC0 · commercial use OK